Clinical Trial Update: Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating PSMA PET/MR-guided SBRT with simultaneous integrated boost for high-intermediate and high-risk prostate cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Prostate Cancer | Phase 2 | Status: RECRUITING